MONTE ROSA THERAPEUTIC
5.0000
08-10月-24 15:59:57
15 分の遅延
株式
-0.0700
-1.38%
本日の幅
4.9500 - 5.1900
ISIN
N/A
ソース
NASDAQ
-
06 9 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Reports Second Quarter 2022 Financial Results and Business Updates
11 8 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Reports First Quarter 2022 Financial Results and Business Updates
11 5 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
29 3 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Announces Participation in Upcoming Investor Conferences
03 2 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
04 1 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer
02 12 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference
22 11 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
10 11 2021 07:30:01 提供 Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics to Present at 4th Annual Targeted Protein Degradation Summit
20 10 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
07 10 2021 09:00:02 提供 Nasdaq GlobeNewswire
-
30 9 2021 16:30:00 提供 Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Announces Addition to Russell 2000® and Russell 3000® Indexes
10 9 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics to Participate in Morgan Stanley 19th Annual Global Healthcare Conference
08 9 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
12 8 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Announces Pricing of Initial Public Offering
23 6 2021 20:20:00 提供 Nasdaq GlobeNewswire